Using a common antibiotic following sex can dramatically reduce a person's risk of some sexually transmitted infections, a ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...

Both studies in JAMA Internal Medicine supported the rising profile of doxyPEP as a way to counter the epidemic of syphilis, gonorrhea, and chlamydia infections, even if the data ...

A new study tracked thousands of gay men taking PrEP and DoxyPEP.  A new study tracked thousands of gay men taking PrEP and ...

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have ...

It was published on Jan. 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication, ...

A new study in JAMA Internal Medicine led by the Harvard Pilgrim Health Care Institute examined whether doxycycline post-exposure prophylaxis (doxyPEP) was associated with declines in bacterial ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

It was published on January 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication ...

Opens in a new tab or window A decrease in California's sexually transmitted infections (STIs) followed early real-world adoption of doxycycline post-exposure prophylaxis (doxyPEP), suggesting ...